Ingo Ott

13.7k total citations · 4 hit papers
205 papers, 11.8k citations indexed

About

Ingo Ott is a scholar working on Organic Chemistry, Oncology and Molecular Biology. According to data from OpenAlex, Ingo Ott has authored 205 papers receiving a total of 11.8k indexed citations (citations by other indexed papers that have themselves been cited), including 159 papers in Organic Chemistry, 128 papers in Oncology and 45 papers in Molecular Biology. Recurrent topics in Ingo Ott's work include Metal complexes synthesis and properties (117 papers), Ferrocene Chemistry and Applications (67 papers) and N-Heterocyclic Carbenes in Organic and Inorganic Chemistry (44 papers). Ingo Ott is often cited by papers focused on Metal complexes synthesis and properties (117 papers), Ferrocene Chemistry and Applications (67 papers) and N-Heterocyclic Carbenes in Organic and Inorganic Chemistry (44 papers). Ingo Ott collaborates with scholars based in Germany, Austria and Spain. Ingo Ott's co-authors include Ronald Gust, Nils Metzler‐Nolte, Gilles Gasser, Riccardo Rubbiani, William S. Sheldrick, Luciano Oehninger, Stefan Wölfl, Hamed Alborzinia, Claudia Schmidt and Suzan Can and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Circulation.

In The Last Decade

Ingo Ott

200 papers receiving 11.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Organometallic Anticancer Compounds

2010 1.4k citations Ingo Ott, Nils Metzler‐Nolte et al. Journal of Medicinal Chemistry profile →
On the medicinal chemistry of gold complexes as anticancer drugs

2009 724 citations Ingo Ott profile →
Non Platinum Metal Complexes as Anti‐cancer Drugs

2007 525 citations Ingo Ott, Ronald Gust Archiv der Pharmazie profile →
N-Heterocyclic carbene metal complexes in medicinal chemistry

2012 478 citations Ingo Ott et al. Dalton Transactions profile →

Peers

Countries citing papers authored by Ingo Ott

Since Specialization

Citations

This map shows the geographic impact of Ingo Ott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingo Ott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingo Ott more than expected).

Fields of papers citing papers by Ingo Ott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingo Ott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingo Ott. The network helps show where Ingo Ott may publish in the future.

Co-authorship network of co-authors of Ingo Ott

This figure shows the co-authorship network connecting the top 25 collaborators of Ingo Ott. A scholar is included among the top collaborators of Ingo Ott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingo Ott. Ingo Ott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Modulation of the mechanism of action of antibacterial silver N-heterocyclic carbene complexes by variation of the halide ligand 2025 ·RSC Advances ·(unknown), Ingo Ott	2
2	A dual approach to cancer treatment: gold(i) terpyridine derivatives as DNA binders and inhibitors of mammalian thioredoxin reductase 2024 ·Inorganic Chemistry Frontiers ·María Gil‐Moles, M. Elena Olmos, José M. López‐de‐Luzuriaga, Ingo Ott, M. Concepción Gimeno	3
3	Synthesis of N-heterocyclic carbene gold(i) complexes from the marine betaine 1,3-dimethylimidazolium-4-carboxylate 2024 ·Dalton Transactions ·(unknown), Dirk Bockfeld, (unknown), Bianka Karge, Thomas Bannenberg, (unknown), Mark Brönstrup, Ingo Ott, Matthias Tamm	6
4	Gold(i) and gold(iii) carbene complexes from the marine betaine norzooanemonin: inhibition of thioredoxin reductase, antiproliferative and antimicrobial activity 2024 ·RSC Medicinal Chemistry ·(unknown), Dirk Bockfeld, (unknown), Petra Lippmann, (unknown), Mark Brönstrup, Ingo Ott, Matthias Tamm	5
5	Silver Organometallics that are Highly Potent Thioredoxin and Glutathione Reductase Inhibitors: Exploring the Correlations of Solution Chemistry with the Strong Antibacterial Effects 2024 ·ACS Infectious Diseases ·(unknown), Bianka Karge, (unknown), Petra Lippmann, Peter G. Jones, Hedda Schrey, Mark Brönstrup, Ingo Ott	12
6	Paraptotic Cell Death as an Unprecedented Mode of Action Observed for New Bipyridine-Silver(I) Compounds Bearing Phosphane Coligands 2024 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), Xavier Fontrodona, Isabel Romero, Paulo J. Costa, (unknown), (unknown), Christine Pirker, (unknown), Alexandra M. M. Antunes, Christian R. Kowol, Ingo Ott, Anamaria Brozović, Andy Sombke, (unknown), Ana Isabel Tomaz, Petra Heffeter, Andreia Valente	6
7	Potent Anticancer Activity of a Dinuclear Gold(I) bis‐N‐Heterocyclic Imine Complex Related to Thioredoxin Reductase Inhibition in Vitro 2023 ·ChemPlusChem ·(unknown), Claudia Schmidt, (unknown), Franziska Hanusch, (unknown), Ingo Ott, Angela Casini, Shigeyoshi Inoue	6
8	Water soluble palladium(ii) and platinum(ii) acyclic diaminocarbene complexes: solution behavior, DNA binding, and antiproliferative activity 2020 ·New Journal of Chemistry ·Tatiyana V. Serebryanskaya, Mikhail A. Kinzhalov, (unknown), (unknown), (unknown), Pavel V. Gushchin, (unknown), (unknown), Taras L. Panikorovskii, Petra Lippmann, Ingo Ott, (unknown), (unknown), Alexander S. Bunev, Vadim P. Boyarskiy, Nina A. Kasyanenko	18
9	Ein Multitarget‐Gold(I)‐Komplex induziert Zytotoxizität im Zusammenhang mit Aneuploidie in HCT‐116‐Kolorektalkarzinomzellen 2020 ·Angewandte Chemie ·Jing‐Jing Zhang, Mohamed A. Abu el Maaty, (unknown), Claudia Schmidt, Julienne K. Muenzner, Rainer Schobert, Stefan Wölfl, Ingo Ott	10
10	A Multitarget Gold(I) Complex Induces Cytotoxicity Related to Aneuploidy in HCT‐116 Colorectal Carcinoma Cells 2020 ·Angewandte Chemie International Edition ·Jing‐Jing Zhang, Mohamed A. Abu el Maaty, (unknown), Claudia Schmidt, Julienne K. Muenzner, Rainer Schobert, Stefan Wölfl, Ingo Ott	59
11	Cyclometalated Pt Complexes of CNC Pincer Ligands: Luminescence and Cytotoxic Evaluation 2020 ·Organometallics ·(unknown), (unknown), (unknown), Ines Neundorf, Petra Lippmann, Ingo Ott, (unknown), Cristian A. Strassert, Nikos L. Doltsinis, Axel Klein	41
12	p53-Dependent Anti-Proliferative and Pro-Apoptotic Effects of a Gold(I) N-Heterocyclic Carbene (NHC) Complex in Colorectal Cancer Cells 2019 ·Frontiers in Oncology ·(unknown), Mohamed A. Abu el Maaty, (unknown), (unknown), Ingo Ott, Stefan Wölfl, Xinlai Cheng	36
13	A Ruthenium(II) N-Heterocyclic Carbene (NHC) Complex with Naphthalimide Ligand Triggers Apoptosis in Colorectal Cancer Cells via Activating the ROS-p38 MAPK Pathway 2018 ·International Journal of Molecular Sciences ·(unknown), (unknown), Jannick Theobald, (unknown), Wojciech Streciwilk, Ingo Ott, Stefan Wölfl, Xinlai Cheng	29
14	Total reflection X-ray fluorescence spectrometry as a tool for the quantification of gold and platinum metallodrugs: Determination of recovery rates and precision in the ppb concentration range 2012 ·Journal of Pharmaceutical and Biomedical Analysis ·Andreas Meyer, (unknown), (unknown), Hermann Wätzig, Ingo Ott	17
15	Metallkomplexe als Proteinkinase‐Hemmstoffe 2010 ·Angewandte Chemie ·Conrad Kunick, Ingo Ott	5
16	[N,N′-Bis(salicylidene)-1,2-phenylenediamine]metal complexes with cell death promoting properties 2009 ·JBIC Journal of Biological Inorganic Chemistry ·(unknown), Ingo Ott, Ana Kitanovic, Igor Kitanović, Hamed Alborzinia, (unknown), Stefan Wölfl, Nils Metzler‐Nolte, Sven Schäfer, William S. Sheldrick, Caroline Bischof, Ulrich Schatzschneider, Ronald Gust	84
17	Dinuclear organoiridium(III) mono- and bis-intercalators with rigid bridging ligands: Synthesis, cytotoxicity and DNA binding 2009 ·Journal of Inorganic Biochemistry ·(unknown), (unknown), Ingo Ott, Ronald Gust, Raphael Stoll, William S. Sheldrick	70
18	Non Platinum Metal Complexes as Anti‐cancer Drugs breakdown → 2007 ·Archiv der Pharmazie ·Ingo Ott, Ronald Gust	525
19	Preclinical and Clinical Studies on the Use of Platinum Complexes for Breast Cancer Treatment 2007 ·Anti-Cancer Agents in Medicinal Chemistry ·Ingo Ott, Ronald Gust	67
20	5-Alkynyl-2′-deoxyuridines: Chromatography-free synthesis and cytotoxicity evaluation against human breast cancer cells 2007 ·Bioorganic & Medicinal Chemistry ·(unknown), Ingo Ott, (unknown), Adam Sniady, Ronald Gust, Roman Dembiński	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact